PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsUrethritis
MeSH D014526 - urethritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014522:Urethral diseases
$
Success rate
D014526: 
Urethritis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyErythromycin lactobionate Erythromycin  1985-03-28   
Erythromycin Robimycin  1982-01-01   
Abbott BiotherapeuticsErythromycin lactobionate Erythrocin  1988-01-04   
Alembic PharmaceuticalsAzithromycin Azithromycin  2020-01-28   
Erythromycin Erythromycin  2023-08-24   
Alkem LaboratoriesErythromycin Erythromycin  2022-07-13   
AllerganErythromycin estolate Erythromycin Estolate  1982-01-01   
Erythromycin stearate Erythromycin Stearate  1982-01-01   
AlpharmaErythromycin Erythromycin  1982-04-19   
Erythromycin estolate Erythromycin Estolate  1982-11-18   
Erythromycin Erythromycin Ethylsuccinate  1982-01-01   
AlraErythromycin, Sulfisoxazole acetyl Eryzole  1988-06-15   
AltanaErythromycin Emgel  1991-08-23   
Amneal PharmaceuticalsAzithromycin Azithromycin  2018-07-19   
Erythromycin Erythromycin  2018-03-09   
Erythromycin Erythromycin Ethylsuccinate  2019-11-01   
ANI PharmaceuticalsErythromycin Erythromycin Ethylsuccinate  1982-01-01   
Erythromycin stearate Erythromycin Stearate  1982-01-01   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
75%
3/4
Phase 3
100%
8/8
Approved: 5Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use